Abstract: The invention relates to a console box arrangement for vehicles comprising a housing having a container and a lid, the lid being pivotably arranged about an axis with respect to the container, from a closed position to a fully opened position in which the container and the lid extend in opposite directions along generally the same longitudinal direction, said housing further includes a cupholder which is pivotable about the axis and shaped so as to accommodate and support a drinking glass, cup, bottle, can or similar object. The invention is characterized in that the cupholder includes a first holder component and a second holder component which are pivotable with respect to each other about the axis so that the first holder component can be accommodated in the container and the second holder component can be accommodated in the lid. By means of the invention, an improved console box arrangement is provided, which gives access to a cupholder for the occupants in both the front and rear seats.

Abstract: Methods and novel intermediates for the preparation of and the treatment with acyclic nucleoside derivatives of the formula: 1

Abstract: The invention relates to a console box arrangement for vehicles comprising a housing (5) having a container (6) and a lid (7), said lid (7) being pivotably arranged about an axis (8) with respect to the container (6), from a closed position to a fully opened position in which the container (6) and the lid (7) extend in opposite directions along generally the same longitudinal direction, said housing (5) further comprising a cupholder (10) which is pivotable about said axis (8) and shaped so as to accommodate and support a drinking glass, cup, bottle, can or similar object (11). The invention is characterized in that the cupholder (10) comprises a first holder component (10a) and a second holder component (10b) which are pivotable with respect to each other about said axis (8) so that the first holder component (10a) can be accommodated in the container (6) and the second holder component (10b) can be accommodated in the lid (7).

Abstract: Methods and novel intermediates for the preparation of and the treatment with acyclic nucleoside derivatives of the formula: where one of R1 and R2 is an amino acid acyl group and the other of R1 and R2 is a —C(O)C3-C21 saturated or monounsaturated, optionally substituted alkyl and R3 is OH or H.

Abstract: A method for treatment of HBV and HIV infections comprising administering the compound or salt of formula Ig 1

Abstract: Compounds of the Formula I where one of R1 and R2 is —C(O)CH(CH(CH3)2)NH2 or —C(O)CH(CH(CH3)CH2CH3)NH2; the other of R1 and R2 is —C(═O)C3-C21 saturated or monounsaturated, optionally substituted alkyl; and R3 is OH or H; and pharmaceutically acceptable salts thereof have utility as enhanced bioavailability antivirals against herpes and retroviral infections.

Abstract: Methods and novel intermediates for the preparation of and the treatment with acyclic nucleoside derivatives of the formula: 1

Abstract: Compounds of the formula I or corresponding monohydroxynucleoside derivatives wherein: R1 is hydroxy, amino or carboxy: optionally having esterified/amide bonded thereon; a C4-C22 saturated or unsaturated, optionally substituted fatty acid or alcohol, or an aliphatic L-amino acid; R2 is the residue of an aliphatic L-amino acid; L1 is a trifunctional linker group; L2 is absent or a difunctional linker group; and pharmaceutically acceptable salts thereof have favorable pharmacological properties and are antivirally active.

Abstract: Non-nucleoside reverse transcriptase inhibitors of formula (P-1) wherein: Ar1 is an unsaturated, optionally substituted, mono or bicyclic ring structure comprising 0 to 3 hetero atoms selected from S, O and N; Ar2 is an aromatic, optionally substituted, monocyclic ring structure comprising at least one nitrogen hetero atom and zero to two further hetero atoms selected from S, O and N; R4 and R5 are independently H or C3-C8 cycloalkyl, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C5 alkoxy, C1-C4 alkanoyloxy, C1-C4 alkylthio, amino, carboxy, carbamoyl, cyano, halo, hydroxy, aminomethyl, hydroxymethyl, carboxymethyl, or halo substituted C1-C6 alkyl mercapto, nitro; or R4 and RS join to form a 3-6 membered, optionally substituted ring structure; R6 is 0 or S; Rx is the residue of a natural or unnatural amino acid; and L* is a linker moiety which is ether-, carbonate- or ester-bound to the adjacent oxygen and ester linked to Rx; and pharmaceutically acceptable salts thereof are anti-HIV agents with favourable ph

Abstract: Use of a compound of the formula wherein Base is thymine, Cytosine, adenine or guanine, or a physiologically acceptable salt thereof, for therapeutic or prophylactic control or treatment of retrovirus infections, including HIV, and hepatitis B virus infections and to a method for such treatment, especially for AIDS.

Abstract: Compounds of the Formula I where one of R1 and R2 is —C(O)CH(CH(CH3)2)NH2 or —C(O)CH(CH(CH3)CH2CH3)NH2; the other of R1 and R2 is —C(═O)C3-C21 saturated or monounsaturated, optionally substituted alkyl; and R3 is OH or H; and pharmaceutically acceptable salts thereof have utility as enhanced bioavailability antivirals against herpes and retroviral infections.

Abstract: A control system in an ATM system controls flows of data cells and flow control management cells from a number of sources to a destination over connections passing a network element. The flow control management cells are returned from the destination via the network element to their respective sources. The network element is exposed to congestion due to contention between the connections, that necessitates queuing of the connections. The flow control management cells have an explicit rate field for an explicit rate value used to limit a source maximum allowed cell rate to a specific value. An operating function uses deviations from an available rate value for lower priority cells and from a queue length reference forming a desirable queue length, to calculate a modified explicit rate value as a function of these deviations. This modified explicit rate value is introduced into the explicit rate field of the backward flow control management cells.

Abstract: Switching equipment with a contactor (CE) and a circuit breaker (BR) located ahead of the contactor. For detection of welded-together contacts of the contactor, this is provided with means (SC) adapted, a certain time after an opening order to the contactor, to apply a voltage pulse to the operating coil (12) of the contactor and to compare the current response of the operating coil with a comparison level for forming a detection signal (s.sub.d), which is supplied to the circuit breaker. Upon detection of welded-together contacts, the detection signal triggers an opening of the circuit breaker for disconnection of the contactor.

Abstract: Contactor equipment with an operating magnet with an operating coil (CW) as well as an armature, which moves in dependence on the current through the operating coil. The contactor has control means (TR, CC, R1. R2, R3) which control the voltage supplied to the operating coil. During the closing operation of the contactor, for utilization of the current-reducing effect of the change of inductance taking place because of the movement of the armature during a closing operation, a voltage is supplied to the operating coil which is substantially constant during the closing operation and independent of the current of the operating coil. After a completed closing operation, the current is controlled through the operating coil in accordance with a reference value.

Abstract: Compounds of the Formula I ##STR1## where one of R.sub.1 and R.sub.2 is --C(O)CH(CH(CH.sub.3).sub.2)NH.sub.2 or --C(O)CH(CH(CH.sub.3)CH.sub.2 CH.sub.3)NH.sub.2;the other of R.sub.1 and R.sub.2 is --C(.dbd.O)C.sub.3 -C.sub.21 saturated or monounsaturated, optionally substituted alkyl; andR.sub.3 is OH or H;and pharmaceutically acceptable salts thereof have utility as enhanced bioavailability antivirals against herpes and retroviral infections.

Abstract: Antivirally active compounds of formula (I), wherein R.sup.1 is hydrogen, hydroxy, mercapto or amino; R.sup.2 is hydrogen, hydroxy, fluoro, chloro or amino; R.sup.3 and R.sup.4 are independently selected from (II), (III), amino, hydroxy or an ether or ester residue thereof, or R.sup.3 together with R.sup.4 is (IV), wherein M is hydrogen or a pharmaceutically acceptable counterion; and n is 1 or 2; with the proviso that, when R.sup.2 is amino and R.sup.3 and R.sup.4 are hydroxy, R.sup.1 is not hydroxy and in addition, when n=1, R.sup.1 is not hydrogen, and pharmaceutically acceptable salts thereof; processes for preparation of said compounds, a pharmaceutical composition comprising said compounds, methods for treatments of virus infections as well as use of compounds of formula (I) without the proviso for the manufacture of a medicament for treatment of AIDS.

Abstract: This invention relates to a method of producing restorations, prosthesis or the like within dentistry and medical service, a measuring device, a computer and a shaping machine being utilized. According to the invention the method is characterized by the combination of the following moments: a measuring probe (3) provided with at least two lighting points (5-7) and being an integral part of a measuring device provided with at least two cameras (1, 2) is conveyed along the treatment area at the same time as the movements of the measuring probe (3) are registered by means of the cameras (1, 2); data from the cameras are collected by and stored in a computer which is specially programmed for this field of use and which on basis of incoming data can determine the form of the treatment area; the data information stored in the computer is utilized for controlling a shaping machine which out of a working piece shapes a suitable restoration or prosthesis.

Abstract: An instrument for measuring the topography of a surface, comprising a light transmitting device for transmitting a light beam onto the surface; a light receiving device for receiving light reflected by the surface; a detector for detecting the position of the received light relative to the optical axis of the light receiving device; and means for providing relative movement between on one hand the light transmitting (10,L1,L2) and light receiving (L3,L4,8) devices, and on the other hand the surface (2) to be measured. According to the invention the optical axis (11) of the light transmitting device (10,L1,L2) is arranged to form a small angle (.gamma..sub.1) with the normal to the median plane (13) of a workpiece surface (2) to be measured. The angle (.gamma..sub.1) is smaller than about 15.degree.. The optical axis (9) of the light receiving device (L3,L4) forms a right angle, or substantially a right angle (8) with the optical axis of the light transmitting device.